_    ___ ___      _                               
   / \  |_ _/ _ \ ___| |_ _ __ ___  __ _ _ __ ___  ___
  / _ \  | | | | / __| __| '__/ _ \/ _` | '_ ` _ \/ __|
 / ___ \ | | |_| \__ \ |_| | |  __/ (_| | | | | | \__ \
/_/   \_\___\___/|___/\__|_|  \___|\__,_|_| |_| |_|___/

Invidious > Channel > EBD Group

EBD Group	1100 subscribers    RSS
View channel on YouTube Videos Playlists

YT 8 minutes EBD Group BIO-Europe Spring® 2017: Partnerships are key for rare disease drug discovery and development YT 11 minutes 27 seconds EBD Group BIO-Europe Spring® 2017: Atriva repurposes cancer drug candidates to create universal flu treatment YT 6 minutes 15 seconds EBD Group BIO-Europe Spring® 2017: Venneos develops next generation label-free cell analysis

YT 8 minutes 1 second EBD Group BIO-Europe Spring® 2017: Newron CEO on Xadago and upcoming pipeline milestones YT 5 minutes 55 seconds EBD Group BIO-Europe Spring® 2017: Chronic constipation device impresses judges in startup competition YT 8 minutes 22 seconds EBD Group BIO-Europe Spring® 2017: Celyad VP talks IP issues, development timelines for CAR-T therapies

YT 5 minutes 9 seconds EBD Group BIO-Europe Spring® 2017: Noxxon CEO discusses partners and cancer combinations YT 10 minutes 2 seconds EBD Group BIO-Europe Spring® 2017: Seventure Partners predicts bright future for microbiome opportunities YT 4 minutes 15 seconds EBD Group BIO-Europe Spring® 2017: Avir BD execs on innovative meds for Canadians

YT 12 minutes 54 seconds EBD Group BIO-Europe Spring® 2017: Infant Bacterial Therapeutics harnesses microbiome to treat preterm babies YT 9 minutes 25 seconds EBD Group BIO-Europe Spring® 2017: Korean pharma spawns US cancer biotech startup YT 8 minutes 34 seconds EBD Group BIO-Europe Spring® 2017: Sinergium provides gateway to Latin American vaccine and biologics markets

YT 8 minutes 28 seconds EBD Group BIO-Europe Spring® 2017: Shanghai Henilus Biotech has blockbuster biologics in biosimilar crosshairs YT 9 minutes 24 seconds EBD Group BIO-Europe Spring® 2017: Imanova trims Phase I and IIa trial timelines and costs YT 8 minutes 4 seconds EBD Group BIO-Europe Spring® 2017: Producing monoclonals for at least a tenth of the cost

YT 9 minutes 41 seconds EBD Group BIO-Europe Spring® 2017: TxCell plans first-in-man trial of regulatory T cells YT 9 minutes 16 seconds EBD Group BIO-Europe Spring® 2017: Mitochondrial medicine focus drives NeuroVive orphan ambitions YT 9 minutes 27 seconds EBD Group BIO-Europe Spring® 2017: vitalityDNA plans to keep healthy indviduals healthy